Nemolizumab, CAS 1476039-58-3

Product Description: Nemolizumab (CIM331) is a humanized antihuman interleukin-31 receptor A monoclonal antibody that inhibits the binding of interleukin-31 (IL-31) to its receptor and subsequent signal transduction. Nemolizumab can used be in research of atopic dermatitis (AD)[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Nakahara T, et, al. Nemolizumab and Atopic Dermatitis: the Interaction Between Interleukin-31 and Interleukin-31 Receptor as a Potential Therapeutic Target for Pruritus in Patients With Atopic Dermatitis. 2018;5:405–14.

CAS Number: 1476039-58-3

Molecular Weight: N/A

Compound Purity: 95.56

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Interleukin Related

• Artikelnummer: MEXHY-P99162-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99162-10
• Green Labware: Nein
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK